CUPRIMINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cuprimine, and when can generic versions of Cuprimine launch?
Cuprimine is a drug marketed by Valeant Pharms Intl and is included in one NDA.
The generic ingredient in CUPRIMINE is penicillamine. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the penicillamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cuprimine
A generic version of CUPRIMINE was approved as penicillamine by WATSON LABS INC on June 24th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CUPRIMINE?
- What are the global sales for CUPRIMINE?
- What is Average Wholesale Price for CUPRIMINE?
Summary for CUPRIMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,592 |
| Drug Prices: | Drug price information for CUPRIMINE |
| What excipients (inactive ingredients) are in CUPRIMINE? | CUPRIMINE excipients list |
| DailyMed Link: | CUPRIMINE at DailyMed |
Recent Clinical Trials for CUPRIMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Merck Sharp & Dohme Corp. |
Pharmacology for CUPRIMINE
| Drug Class | Antirheumatic Agent |
US Patents and Regulatory Information for CUPRIMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharms Intl | CUPRIMINE | penicillamine | CAPSULE;ORAL | 019853-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Valeant Pharms Intl | CUPRIMINE | penicillamine | CAPSULE;ORAL | 019853-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
